Integrative network analysis identifies an immune-based prognostic signature as the determinant for the mesenchymal subtype in epithelial ovarian cancer

MLA

Xiaoyan Lu, et al. “Integrative Network Analysis Identifies an Immune-Based Prognostic Signature as the Determinant for the Mesenchymal Subtype in Epithelial Ovarian Cancer.” Medicine, vol. 99, Oct. 2020, p. e22549. EBSCOhost, https://doi.org/10.1097/md.0000000000022549.

APA

Xiaoyan Lu, Mingyan Sheng, Peng Shu, Xingguo Zhang, Ni Shanshan, B. A. Ashok Reddy, & Haofei Tong. (2020). Integrative network analysis identifies an immune-based prognostic signature as the determinant for the mesenchymal subtype in epithelial ovarian cancer. Medicine, 99, e22549. https://doi.org/10.1097/md.0000000000022549

Chicago

Xiaoyan Lu, Mingyan Sheng, Peng Shu, Xingguo Zhang, Ni Shanshan, B. A. Ashok Reddy, and Haofei Tong. 2020. “Integrative Network Analysis Identifies an Immune-Based Prognostic Signature as the Determinant for the Mesenchymal Subtype in Epithelial Ovarian Cancer.” Medicine 99 (October): e22549. doi:10.1097/md.0000000000022549.